Hepatitis B Vaccine

Hepatitis B Vaccine: Essential Steps for Protecting At-Risk Infants

Key Takeaways

The Risk of HepB for At-Risk Infants
The Hepatitis B Vaccination Schedule for At-Risk Infants
Key Reminders for Parents and Healthcare Providers
Testing and Follow-Up: The Dried Blood Spot (DBS) Test
Administrative and Financial Considerations
Conclusion
Frequently Asked Questions

Hepatitis B is a serious viral infection that can be passed from mother to child during birth. For infants born to hepatitis B positive mothers, the risk of developing chronic hepatitis B is alarmingly high—up to 90% if left unprotected. Chronic infection can lead to liver cirrhosis, cancer, and lifelong health complications. The good news is that with a precise vaccination schedule and timely follow-up, these risks can be dramatically reduced.

The Hepatitis B Vaccination Schedule for At-Risk Infants

The Six-Dose Pathway

2. Routine Hexavalent Vaccines

Vaccination Schedule Table

Key Reminders for Parents and Healthcare Providers

Register Early and Communicate

Book Appointments in Advance

Monitor and Support

Testing and Follow-Up: The Dried Blood Spot (DBS) Test

Why the DBS Test Matters

At 12 months, a Dried Blood Spot (DBS) test is performed to screen for hepatitis B infection. This test is not for checking immunity, but to confirm that the infant has not become infected despite vaccination.

  • If the test is negative: The child is considered protected, and no further hepatitis B vaccines are needed.
  • If the test is positive: The child will need referral to a specialist for further assessment and management.

How the DBS Test Works

Importance of Timely Testing

Administrative and Financial Considerations

Reimbursement for Monovalent Doses

Documentation and Record-Keeping

Conclusion

The Medicines Management Team offers resources and guidance for both parents and healthcare professionals. Contact your local TMMT representative or visit our website for more information.

Author

  • Director, The Medicines Management Team

    Mohammed Rashad is a pharmacist and Director at The Medicines Management Team (TMMT), an award-winning provider of pharmacy services supporting over 85 Primary Care Networks (PCNs) and 250 GP practices across the UK. He works at scale with practices and PCNs to reduce workload, improve access, and deliver key targets such as QOF. Mohammed combines clinical expertise with strategic leadership to redesign how primary care operates. He leads on digital innovation, implementing performance dashboards, optimising workflows, and using data to drive smarter decisions. His work focuses on building scalable, high-performing models that deliver measurable impact. He regularly shares practical insights on improving efficiency, workforce productivity, and patient outcomes across primary care.

Related Blogs